je.st
news
a Biogen blames lower-than-expected Tecfidera sales partly on safety concerns
2015-04-24 22:54:30| Biotech - Topix.net
Biogen's Tecfidera was the biggest locally-developed drug to be approved in the U.S. in 2013. It's expected to make more than $4 billion in revenue in 2018.
Tags: sales
safety
concerns
partly
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||